BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chen WX, Ren LH, Shi RH. Implication of miRNAs for inflammatory bowel disease treatment: Systematic review. World J Gastrointest Pathophysiol 2014; 5(2): 63-70 [PMID: 24891977 DOI: 10.4291/wjgp.v5.i2.63] [Cited by in CrossRef: 60] [Cited by in F6Publishing: 67] [Article Influence: 7.5] [Reference Citation Analysis]
Number Citing Articles
1 Russo E, Cinci L, Di Gloria L, Baldi S, D’ambrosio M, Nannini G, Bigagli E, Curini L, Pallecchi M, Andrea Arcese D, Scaringi S, Malentacchi C, Bartolucci G, Ramazzotti M, Luceri C, Amedei A, Giudici F. Crohn’s disease recurrence updates: first surgery vs. surgical relapse patients display different profiles of ileal microbiota and systemic microbial-associated inflammatory factors. Front Immunol 2022;13:886468. [DOI: 10.3389/fimmu.2022.886468] [Reference Citation Analysis]
2 Yarani R, Shojaeian A, Palasca O, Doncheva NT, Jensen LJ, Gorodkin J, Pociot F. Differentially Expressed miRNAs in Ulcerative Colitis and Crohn’s Disease. Front Immunol 2022;13:865777. [DOI: 10.3389/fimmu.2022.865777] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Hu W, Fang T, Chen X. Identification of Differentially Expressed Genes and miRNAs for Ulcerative Colitis Using Bioinformatics Analysis. Front Genet 2022;13:914384. [DOI: 10.3389/fgene.2022.914384] [Reference Citation Analysis]
4 Rashid H, Siddiqua TJ, Hossain B, Siddique A, Kabir M, Noor Z, Alam M, Ahmed M, Haque R. MicroRNA Expression and Intestinal Permeability in Children Living in a Slum Area of Bangladesh. Front Mol Biosci 2021;8:765301. [PMID: 34957214 DOI: 10.3389/fmolb.2021.765301] [Reference Citation Analysis]
5 Moret-Tatay I, Cerrillo E, Hervás D, Iborra M, Sáez-González E, Forment J, Tortosa L, Nos P, Gadea J, Beltrán B. Specific Plasma MicroRNA Signatures in Predicting and Confirming Crohn's Disease Recurrence: Role and Pathogenic Implications. Clin Transl Gastroenterol 2021;12:e00416. [PMID: 34695034 DOI: 10.14309/ctg.0000000000000416] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
6 Bastami M, Masotti A, Saadatian Z, Daraei A, Farjam M, Ghanbariasad A, Vahed SZ, Eyvazi S, Mansoori Y, Nariman-Saleh-Fam Z. Critical roles of microRNA-196 in normal physiology and non-malignant diseases: Diagnostic and therapeutic implications. Exp Mol Pathol 2021;122:104664. [PMID: 34166682 DOI: 10.1016/j.yexmp.2021.104664] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
7 Duan XY, Sun Y, Zhao ZF, Shi YQ, Ma XY, Tao L, Liu MW. Baicalin attenuates LPS-induced alveolar type II epithelial cell A549 injury by attenuation of the FSTL1 signaling pathway via increasing miR-200b-3p expression. Innate Immun 2021;27:294-312. [PMID: 34000873 DOI: 10.1177/17534259211013887] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
8 Jung H, Kim JS, Lee KH, Tizaoui K, Terrazzino S, Cargnin S, Smith L, Koyanagi A, Jacob L, Li H, Hong SH, Yon DK, Lee SW, Kim MS, Wasuwanich P, Karnsakul W, Shin JI, Kronbichler A. Roles of microRNAs in inflammatory bowel disease. Int J Biol Sci 2021;17:2112-23. [PMID: 34131410 DOI: 10.7150/ijbs.59904] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Wang P, Chen Y, Zhang LM, Yuan SQ, Lu SA, Zhang YJ. Effect of MicroRNA145 on the multidrug resistance gene of ulcerative colitis in rats. Life Sci 2021;278:119603. [PMID: 33984358 DOI: 10.1016/j.lfs.2021.119603] [Reference Citation Analysis]
10 Zhao J, Wang H, Zhou J, Qian J, Yang H, Zhou Y, Ding H, Gong Y, Qi X, Jiao Y, Ying P, Tang L, Sun Y, Zhu W. miR-130a-3p, a Preclinical Therapeutic Target for Crohn's Disease. J Crohns Colitis 2021;15:647-64. [PMID: 33022049 DOI: 10.1093/ecco-jcc/jjaa204] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
11 Zhou W, Zhang H, Pan Y, Xu Y, Cao Y. circRNA expression profiling of colon tissue from mesalazine-treated mouse of inflammatory bowel disease reveals an important circRNA-miRNA-mRNA pathway. Aging (Albany NY) 2021;13:10187-207. [PMID: 33819198 DOI: 10.18632/aging.202780] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
12 Farsi F, Ebrahimi-Daryani N, Golab F, Akbari A, Janani L, Karimi MY, Irandoost P, Alamdari NM, Agah S, Vafa M. A randomized controlled trial on the coloprotective effect of coenzyme Q10 on immune-inflammatory cytokines, oxidative status, antimicrobial peptides, and microRNA-146a expression in patients with mild-to-moderate ulcerative colitis. Eur J Nutr 2021;60:3397-410. [PMID: 33620550 DOI: 10.1007/s00394-021-02514-2] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
13 Nazimek K; Department of Immunology, Jagiellonian University Medical College, 18 Czysta St., 31-121 Krakow, Poland. . ALLERGY 2021;5:195-221. [DOI: 10.3934/allergy.2021016] [Reference Citation Analysis]
14 Zobeiri M, Momtaz S, Parvizi F, Tewari D, Farzaei MH, Nabavi SM. Targeting Mitogen-Activated Protein Kinases by Natural Products: A Novel Therapeutic Approach for Inflammatory Bowel Diseases. Curr Pharm Biotechnol 2020;21:1342-53. [PMID: 31840607 DOI: 10.2174/1389201021666191216122555] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
15 James JP, Riis LB, Malham M, Høgdall E, Langholz E, Nielsen BS. MicroRNA Biomarkers in IBD-Differential Diagnosis and Prediction of Colitis-Associated Cancer. Int J Mol Sci 2020;21:E7893. [PMID: 33114313 DOI: 10.3390/ijms21217893] [Cited by in Crossref: 5] [Cited by in F6Publishing: 21] [Article Influence: 2.5] [Reference Citation Analysis]
16 Wajda A, Łapczuk-Romańska J, Paradowska-Gorycka A. Epigenetic Regulations of AhR in the Aspect of Immunomodulation. Int J Mol Sci 2020;21:E6404. [PMID: 32899152 DOI: 10.3390/ijms21176404] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
17 Chen H, Zeng L, Zheng W, Li X, Lin B. Increased Expression of microRNA-141-3p Improves Necrotizing Enterocolitis of Neonates Through Targeting MNX1. Front Pediatr 2020;8:385. [PMID: 32850524 DOI: 10.3389/fped.2020.00385] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
18 Lin L, Zhou G, Chen P, Wang Y, Han J, Chen M, He Y, Zhang S. Which long noncoding RNAs and circular RNAs contribute to inflammatory bowel disease? Cell Death Dis 2020;11:456. [PMID: 32541691 DOI: 10.1038/s41419-020-2657-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
19 Zhang H, Xue S, Feng Y, Shen J, Zhao J. MicroRNA-24-3p inhibition prevents cell growth of vascular smooth muscle cells by targeting Bcl-2-like protein 11. Exp Ther Med 2020;19:2467-74. [PMID: 32256723 DOI: 10.3892/etm.2020.8517] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
20 Konstantinidis AΟ, Pardali D, Adamama-Moraitou KK, Gazouli M, Dovas CI, Legaki E, Brellou GD, Savvas I, Jergens AE, Rallis TS, Allenspach K. Colonic mucosal and serum expression of microRNAs in canine large intestinal inflammatory bowel disease. BMC Vet Res 2020;16:69. [PMID: 32087719 DOI: 10.1186/s12917-020-02287-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
21 Liu X, Zhang Y, Jiang P, Cai J, Fu Q, Li X, Li Z. Ultrasonic cardiogram and MiRNA-21 analysis of cardiac dysfunction in patients with cardiac arrest following cardiopulmonary resuscitation. Comput Methods Programs Biomed 2020;190:105284. [PMID: 32018074 DOI: 10.1016/j.cmpb.2019.105284] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
22 Minacapelli CD, Bajpai M, Geng X, Van Gurp J, Poplin E, Amenta PS, Brant SR, Das KM. miR-206 as a Biomarker for Response to Mesalamine Treatment in Ulcerative Colitis. Inflamm Bowel Dis 2019;25:78-84. [PMID: 30204869 DOI: 10.1093/ibd/izy279] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
23 Kumar V, Torben W, Mansfield J, Alvarez X, Vande Stouwe C, Li J, Byrareddy SN, Didier PJ, Pahar B, Molina PE, Mohan M. Cannabinoid Attenuation of Intestinal Inflammation in Chronic SIV-Infected Rhesus Macaques Involves T Cell Modulation and Differential Expression of Micro-RNAs and Pro-inflammatory Genes. Front Immunol 2019;10:914. [PMID: 31114576 DOI: 10.3389/fimmu.2019.00914] [Cited by in Crossref: 11] [Cited by in F6Publishing: 17] [Article Influence: 3.7] [Reference Citation Analysis]
24 Tian Y, Xu J, Li Y, Zhao R, Du S, Lv C, Wu W, Liu R, Sheng X, Song Y, Bi X, Li G, Li M, Wu X, Lou P, You H, Cui W, Sun J, Shuai J, Ren F, Zhang B, Guo M, Hou X, Wu K, Xue L, Zhang H, Plikus MV, Cong Y, Lengner CJ, Liu Z, Yu Z. MicroRNA-31 Reduces Inflammatory Signaling and Promotes Regeneration in Colon Epithelium, and Delivery of Mimics in Microspheres Reduces Colitis in Mice.Gastroenterology. 2019;156:2281-2296.e6. [PMID: 30779922 DOI: 10.1053/j.gastro.2019.02.023] [Cited by in Crossref: 49] [Cited by in F6Publishing: 79] [Article Influence: 16.3] [Reference Citation Analysis]
25 Tang WJ, Peng KY, Tang ZF, Wang YH, Xue AJ, Huang Y. MicroRNA-15a - cell division cycle 42 signaling pathway in pathogenesis of pediatric inflammatory bowel disease. World J Gastroenterol 2018; 24(46): 5234-5245 [PMID: 30581272 DOI: 10.3748/wjg.v24.i46.5234] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 18] [Article Influence: 4.8] [Reference Citation Analysis]
26 Moein S, Vaghari-Tabari M, Qujeq D, Majidinia M, Nabavi SM, Yousefi B. MiRNAs and inflammatory bowel disease: An interesting new story. J Cell Physiol 2019;234:3277-93. [PMID: 30417350 DOI: 10.1002/jcp.27173] [Cited by in Crossref: 21] [Cited by in F6Publishing: 28] [Article Influence: 5.3] [Reference Citation Analysis]
27 Chao G, Wang Y, Ye F, Zhang S. Regulation of Colonic Mucosal MicroRNA Expression via Multiple Targets in Visceral Hypersensitivity Rats by Tongxieyaofang. Yonsei Med J 2018;59:945-50. [PMID: 30187701 DOI: 10.3349/ymj.2018.59.8.945] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
28 Li Z, Wang Y, Zhu Y. Association of miRNA-146a rs2910164 and miRNA-196 rs11614913 polymorphisms in patients with ulcerative colitis: A meta-analysis and review. Medicine (Baltimore) 2018;97:e12294. [PMID: 30278502 DOI: 10.1097/MD.0000000000012294] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
29 Omidbakhsh A, Saeedi M, Khoshnia M, Marjani A, Hakimi S. Micro-RNAs -106a and -362-3p in Peripheral Blood of Inflammatory Bowel Disease Patients. Open Biochem J 2018;12:78-86. [PMID: 30069249 DOI: 10.2174/1874091X01812010078] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
30 Wen B, Tokar T, Taibi A, Chen J, Jurisica I, Comelli EM. Citrobacter rodentium alters the mouse colonic miRNome. Genes Immun 2019;20:207-13. [PMID: 29728609 DOI: 10.1038/s41435-018-0026-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
31 Wu W, He Y, Feng X, Ye S, Wang H, Tan W, Yu C, Hu J, Zheng R, Zhou Y. MicroRNA-206 is involved in the pathogenesis of ulcerative colitis via regulation of adenosine A3 receptor. Oncotarget 2017;8:705-21. [PMID: 27893428 DOI: 10.18632/oncotarget.13525] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 6.8] [Reference Citation Analysis]
32 ElSharawy A, Röder C, Becker T, Habermann JK, Schreiber S, Rosenstiel P, Kalthoff H. Concentration of circulating miRNA-containing particles in serum enhances miRNA detection and reflects CRC tissue-related deregulations. Oncotarget 2016;7:75353-65. [PMID: 27683108 DOI: 10.18632/oncotarget.12205] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
33 Jiang D, Wang H, Li Z, Li Z, Chen X, Cai H. MiR-142 inhibits the development of cervical cancer by targeting HMGB1. Oncotarget 2017;8:4001-7. [PMID: 27829233 DOI: 10.18632/oncotarget.13136] [Cited by in Crossref: 19] [Cited by in F6Publishing: 24] [Article Influence: 4.8] [Reference Citation Analysis]
34 Li Y, Wu Y. MiR-200-3p inhibits tumor cell proliferation and induces apoptosis by upregulation of FOXO1 in osteosarcoma cells. Mol Cell Toxicol 2018;14:73-8. [DOI: 10.1007/s13273-018-0009-1] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
35 Jiang H, Shen J, Ran Z. Epithelial-mesenchymal transition in Crohn's disease. Mucosal Immunol. 2018;11:294-303. [PMID: 29346350 DOI: 10.1038/mi.2017.107] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 3.8] [Reference Citation Analysis]
36 Mishra P, Singh D, Ganju L, Kumar B. MicroRNA in gastrointestinal cell signalling. Inflammopharmacology 2018;26:1-14. [PMID: 29110118 DOI: 10.1007/s10787-017-0414-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
37 Chu F, Hu Y, Zhou Y, Guo M, Lu J, Zheng W, Xu H, Zhao J, Xu L. MicroRNA-126 deficiency enhanced the activation and function of CD4+ T cells by elevating IRS-1 pathway. Clin Exp Immunol 2018;191:166-79. [PMID: 28987000 DOI: 10.1111/cei.13067] [Cited by in Crossref: 7] [Cited by in F6Publishing: 17] [Article Influence: 1.4] [Reference Citation Analysis]
38 Xiong Y, Shi L, Wang L, Zhou Z, Wang C, Lin Y, Luo D, Qiu J, Chen D. Activation of sirtuin 1 by catalpol-induced down-regulation of microRNA-132 attenuates endoplasmic reticulum stress in colitis. Pharmacological Research 2017;123:73-82. [DOI: 10.1016/j.phrs.2017.05.030] [Cited by in Crossref: 20] [Cited by in F6Publishing: 25] [Article Influence: 4.0] [Reference Citation Analysis]
39 Rodríguez-Nogales A, Algieri F, Garrido-Mesa J, Vezza T, Utrilla MP, Chueca N, Garcia F, Olivares M, Rodríguez-Cabezas ME, Gálvez J. Differential intestinal anti-inflammatory effects of Lactobacillus fermentum and Lactobacillus salivarius in DSS mouse colitis: impact on microRNAs expression and microbiota composition. Mol Nutr Food Res 2017;61. [PMID: 28752563 DOI: 10.1002/mnfr.201700144] [Cited by in Crossref: 57] [Cited by in F6Publishing: 81] [Article Influence: 11.4] [Reference Citation Analysis]
40 Zacharopoulou E, Gazouli M, Tzouvala M, Vezakis A, Karamanolis G. The contribution of long non-coding RNAs in Inflammatory Bowel Diseases. Dig Liver Dis. 2017;49:1067-1072. [PMID: 28869157 DOI: 10.1016/j.dld.2017.08.003] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 6.4] [Reference Citation Analysis]
41 Valmiki S, Ahuja V, Paul J. MicroRNA exhibit altered expression in the inflamed colonic mucosa of ulcerative colitis patients. World J Gastroenterol 2017; 23(29): 5324-5332 [PMID: 28839432 DOI: 10.3748/wjg.v23.i29.5324] [Cited by in CrossRef: 34] [Cited by in F6Publishing: 31] [Article Influence: 6.8] [Reference Citation Analysis]
42 Shindo Y, Hazama S, Nakamura Y, Inoue Y, Kanekiyo S, Suzuki N, Takenouchi H, Tsunedomi R, Nakajima M, Ueno T, Takeda S, Yoshino S, Okuno K, Fujita Y, Hamamoto Y, Kawakami Y, Oka M, Nagano H. miR-196b, miR-378a and miR-486 are predictive biomarkers for the efficacy of vaccine treatment in colorectal cancer. Oncol Lett 2017;14:1355-62. [PMID: 28789351 DOI: 10.3892/ol.2017.6303] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 2.6] [Reference Citation Analysis]
43 Kim HY, Kwon HY, Ha Thi HT, Lee HJ, Kim GI, Hahm KB, Hong S. MicroRNA-132 and microRNA-223 control positive feedback circuit by regulating FOXO3a in inflammatory bowel disease. J Gastroenterol Hepatol. 2016;31:1727-1735. [PMID: 26878986 DOI: 10.1111/jgh.13321] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 6.2] [Reference Citation Analysis]
44 Huang Y, Ma Z, Cui YH, Dong HS, Zhao JM, Dou CZ, Liu HR, Li J, Wu HG. Effects of Herb-Partitioned Moxibustion on the miRNA Expression Profiles in Colon from Rats with DSS-Induced Ulcerative Colitis. Evid Based Complement Alternat Med 2017;2017:1767301. [PMID: 28246536 DOI: 10.1155/2017/1767301] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
45 Béres NJ, Kiss Z, Sztupinszki Z, Lendvai G, Arató A, Sziksz E, Vannay Á, Szabó AJ, Müller KE, Cseh Á, Boros K, Veres G. Altered mucosal expression of microRNAs in pediatric patients with inflammatory bowel disease. Dig Liver Dis 2017;49:378-87. [PMID: 28077249 DOI: 10.1016/j.dld.2016.12.022] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
46 Shen Y, Zhou M, Yan J, Gong Z, Xiao Y, Zhang C, Du P, Chen Y. miR-200b inhibits TNF-α-induced IL-8 secretion and tight junction disruption of intestinal epithelial cells in vitro.Am J Physiol Gastrointest Liver Physiol. 2017;312:G123-G132. [PMID: 27979826 DOI: 10.1152/ajpgi.00316.2016] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 6.0] [Reference Citation Analysis]
47 Zhang HJZ, Yang H, Hu YS, Wang X, Wu QF. Progress in epigenetic research of ulcerative colitis. Shijie Huaren Xiaohua Zazhi 2016; 24(34): 4584-4588 [DOI: 10.11569/wcjd.v24.i34.4584] [Reference Citation Analysis]
48 Wang J, Liu H, Tian L, Wang F, Han L, Zhang W, Bai YA. miR-15b Inhibits the Progression of Glioblastoma Cells Through Targeting Insulin-like Growth Factor Receptor 1. Horm Cancer 2017;8:49-57. [PMID: 27896672 DOI: 10.1007/s12672-016-0276-z] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 2.5] [Reference Citation Analysis]
49 Becker E, Bengs S, Aluri S, Opitz L, Atrott K, Stanzel C, Castro PAR, Rogler G, Frey-Wagner I. Doxycycline, metronidazole and isotretinoin: Do they modify microRNA/mRNA expression profiles and function in murine T-cells? Sci Rep 2016;6:37082. [PMID: 27853192 DOI: 10.1038/srep37082] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
50 Putignani L, Del Chierico F, Vernocchi P, Cicala M, Cucchiara S, Dallapiccola B; Dysbiotrack Study Group. Gut Microbiota Dysbiosis as Risk and Premorbid Factors of IBD and IBS Along the Childhood-Adulthood Transition. Inflamm Bowel Dis 2016;22:487-504. [PMID: 26588090 DOI: 10.1097/MIB.0000000000000602] [Cited by in Crossref: 70] [Cited by in F6Publishing: 66] [Article Influence: 11.7] [Reference Citation Analysis]
51 Béres NJ, Szabó D, Kocsis D, Szűcs D, Kiss Z, Müller KE, Lendvai G, Kiss A, Arató A, Sziksz E, Vannay Á, Szabó AJ, Veres G. Role of Altered Expression of miR-146a, miR-155, and miR-122 in Pediatric Patients with Inflammatory Bowel Disease. Inflamm Bowel Dis 2016;22:327-35. [PMID: 26752469 DOI: 10.1097/MIB.0000000000000687] [Cited by in Crossref: 48] [Cited by in F6Publishing: 43] [Article Influence: 8.0] [Reference Citation Analysis]
52 Pierdomenico M, Cesi V, Cucchiara S, Vitali R, Prete E, Costanzo M, Aloi M, Oliva S, Stronati L. NOD2 Is Regulated By Mir-320 in Physiological Conditions but this Control Is Altered in Inflamed Tissues of Patients with Inflammatory Bowel Disease. Inflamm Bowel Dis. 2016;22:315-326. [PMID: 26752466 DOI: 10.1097/MIB.0000000000000659] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 6.7] [Reference Citation Analysis]
53 Guo J, Jiang X, Gui S. RNA interference-based nanosystems for inflammatory bowel disease therapy. Int J Nanomedicine 2016;11:5287-310. [PMID: 27789943 DOI: 10.2147/IJN.S116902] [Cited by in Crossref: 26] [Cited by in F6Publishing: 30] [Article Influence: 4.3] [Reference Citation Analysis]
54 Hao W, Luo W, Bai M, Li J, Bai X, Guo J, Wu J, Wang M. MicroRNA-206 Inhibited the Progression of Glioblastoma Through BCL-2. J Mol Neurosci 2016;60:531-8. [PMID: 27558109 DOI: 10.1007/s12031-016-0824-6] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 2.7] [Reference Citation Analysis]
55 Szűcs D, Béres NJ, Rokonay R, Boros K, Borka K, Kiss Z, Arató A, Szabó AJ, Vannay &, Sziksz E, Bereczki C, Veres G. Increased duodenal expression of miR-146a and -155 in pediatric Crohn’s disease. World J Gastroenterol 2016; 22(26): 6027-6035 [PMID: 27468194 DOI: 10.3748/wjg.v22.i26.6027] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
56 Suttamanatwong S. MicroRNAs in bone development and their diagnostic and therapeutic potentials in osteoporosis. Connect Tissue Res 2017;58:90-102. [PMID: 26963177 DOI: 10.3109/03008207.2016.1139580] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
57 Whiteoak SR, Felwick R, Sanchez-Elsner T, Fraser Cummings JR. MicroRNAs in inflammatory bowel diseases: paradoxes and possibilities. Inflamm Bowel Dis. 2015;21:1160-1165. [PMID: 25844960 DOI: 10.1097/mib.0000000000000288] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.5] [Reference Citation Analysis]
58 Moret-Tatay I, Iborra M, Cerrillo E, Tortosa L, Nos P, Beltrán B. Possible Biomarkers in Blood for Crohn's Disease: Oxidative Stress and MicroRNAs-Current Evidences and Further Aspects to Unravel. Oxid Med Cell Longev 2016;2016:2325162. [PMID: 26823944 DOI: 10.1155/2016/2325162] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 2.7] [Reference Citation Analysis]
59 Krissansen GW, Yang Y, McQueen FM, Leung E, Peek D, Chan YC, Print C, Dalbeth N, Williams M, Fraser AG. Overexpression of miR-595 and miR-1246 in the sera of patients with active forms of inflammatory bowel disease. Inflamm Bowel Dis 2015;21:520-30. [PMID: 25628040 DOI: 10.1097/MIB.0000000000000285] [Cited by in Crossref: 38] [Cited by in F6Publishing: 33] [Article Influence: 5.4] [Reference Citation Analysis]
60 Guo L, Zhang Y, Zhang L, Huang F, Li J, Wang S. MicroRNAs, TGF-β signaling, and the inflammatory microenvironment in cancer. Tumour Biol 2016;37:115-25. [PMID: 26563372 DOI: 10.1007/s13277-015-4374-2] [Cited by in Crossref: 58] [Cited by in F6Publishing: 63] [Article Influence: 8.3] [Reference Citation Analysis]
61 Hübenthal M, Hemmrich-Stanisak G, Degenhardt F, Szymczak S, Du Z, Elsharawy A, Keller A, Schreiber S, Franke A. Sparse Modeling Reveals miRNA Signatures for Diagnostics of Inflammatory Bowel Disease. PLoS One. 2015;10:e0140155. [PMID: 26466382 DOI: 10.1371/journal.pone.0140155] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 3.0] [Reference Citation Analysis]
62 Serban DE. Microbiota in Inflammatory Bowel Disease Pathogenesis and Therapy: Is It All About Diet? Nutr Clin Pract 2015;30:760-79. [DOI: 10.1177/0884533615606898] [Cited by in Crossref: 47] [Cited by in F6Publishing: 42] [Article Influence: 6.7] [Reference Citation Analysis]
63 Pathak S, Grillo AR, Scarpa M, Brun P, D’Incà R, Nai L, Banerjee A, Cavallo D, Barzon L, Palù G. MiR-155 modulates the inflammatory phenotype of intestinal myofibroblasts by targeting SOCS1 in ulcerative colitis. Exp Mol Med. 2015;47:e164. [PMID: 25998827 DOI: 10.1038/emm.2015.21] [Cited by in Crossref: 47] [Cited by in F6Publishing: 58] [Article Influence: 6.7] [Reference Citation Analysis]
64 Zang WQ, Yang X, Wang T, Wang YY, Du YW, Chen XN, Li M, Zhao GQ. MiR-451 inhibits proliferation of esophageal carcinoma cell line EC9706 by targeting CDKN2D and MAP3K1. World J Gastroenterol 2015; 21(19): 5867-5876 [PMID: 26019450 DOI: 10.3748/wjg.v21.i19.5867] [Cited by in CrossRef: 29] [Cited by in F6Publishing: 27] [Article Influence: 4.1] [Reference Citation Analysis]
65 Wang R, Ma Y, Yu D, Zhao J, Ma P. miR-377 functions as a tumor suppressor in human clear cell renal cell carcinoma by targeting ETS1. Biomedicine & Pharmacotherapy 2015;70:64-71. [DOI: 10.1016/j.biopha.2015.01.012] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 3.6] [Reference Citation Analysis]
66 Yashiro M. Ulcerative colitis-associated colorectal cancer. World J Gastroenterol 2014; 20(44): 16389-16397 [PMID: 25469007 DOI: 10.3748/wjg.v20.i44.16389] [Cited by in CrossRef: 125] [Cited by in F6Publishing: 107] [Article Influence: 15.6] [Reference Citation Analysis]
67 Li W, Zang W, Liu P, Wang Y, Du Y, Chen X, Deng M, Sun W, Wang L, Zhao G, Zhai B. MicroRNA-124 inhibits cellular proliferation and invasion by targeting Ets-1 in breast cancer. Tumour Biol 2014;35:10897-904. [PMID: 25085587 DOI: 10.1007/s13277-014-2402-2] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 4.3] [Reference Citation Analysis]